Experimed

GÖNDERBİLGİ
EnglishTürkçe

Araştırma Makalesi


DOI :10.26650/experimed.2018.430561   IUP :10.26650/experimed.2018.430561    Tam Metin (PDF)

Diyaliz Tedavisi Uygulanan ve Uygulanmayan Kronik Böbrek Yetmezlikli Hastalarda Protein Oksidasyon Ürünlerinin Değerlendirilmesi

Cihan Coşkun, Alev Kural, Macit Koldaş

Amaç: Bu çalışmada replasman tedavisi alan ve almayan kronik böbrek yetmezliği (KBY) hastalarının kan protein oksidasyon ürünlerinin düzeylerini değerlendirmek ve hasta kişiler ile sağlıklı kişileri karşılaştırmak için kontrol grubu (n=35) ve hasta grupları oluşturuldu.


Gereç ve Yöntem: Hasta grupları replasman tedavisi almayan KBY hasta grubu (n=36), hemodiyaliz (HD) tedavisi gören hasta grubu (n=64) ve periton diyaliz (PD) tedavisi gören hasta grubu (n=21) olmak üzere şekillendirildi. Daha sonra ileri düzey okside protein ürünleri (AOPP) ve ileri glikasyon son ürünleri (AGE)’in düzeyleri bakımından bu gruplar değerlendirildi.


Bulgular: Sonuç olarak, replasman tedavisi almayan KBY hasta grubunun AGE düzeyleri haricinde, diğer tüm grupların AOPP ve AGE düzeylerinin kontrol grubuna göre artmış olduğu saptandı. İstatistiksel olarak en önemli artışın ise HD hasta grubunda olduğu tespit edildi. Grup içi değerlendirmeler sonucunda hiçbir grupta AOPP ve AGE düzeyleri arasında ilişki saptanmadı.


Sonuç: Bu sonuçlara göre KBY’nin oksidatif stresle birlikte seyrettiği, replasman tedavisi gören KBY hastalarında ve özellikle de HD tedavisi gören hastalarda oksidatif stresin çok daha şiddetli olduğu gözlemlendi. Son olarak, HD tedavisi gören gruptaki hastaların diyabet olup olmamasının sonuçları etkilemediği görüldü.

Anahtar Kelimeler: Kronik böbrek yetmezliği, hemodiyaliz, periton diyalizi, ileri düzey okside protein ürünleri, ileri glikasyon son ürünleri
DOI :10.26650/experimed.2018.430561   IUP :10.26650/experimed.2018.430561    Tam Metin (PDF)

Evaluation of Protein Oxidation Products in Patients With Chronic Renal Failure Receiving Dialysis or Not

Cihan Coşkun, Alev Kural, Macit Koldaş

Objective: In this study, control (n=35) and groups were formed to evaluate the levels of blood protein oxidation products in patients with chronic renal failure (CRF) who did and did not receive replacement therapy and to compare the patients with healthy subjects.


Material and Method: The groups were the CRF (n=36) group that did not receive replacement therapy, patients who were undergoing hemodialysis (HD) (n=64), and patients who were undergoing peritoneal dialysis (PD) (n=21). These groups were evaluated for the production of advanced oxidation protein product (AOPP) and advanced glycated end product (AGE) levels.


Results: As results, the AOPP and AGE values of all groups increased compared to the control group, except for the AGE levels of the patients with CRF who did not receive replacement therapy. The most significant increase was found in the HD patient group. No relationship was detected between the AOPP and AGE values in any group.


Conclusion: According to these results, CRF is accompanied by oxidative stress, and the oxidative stress is much more severe in patients with CRF receiving replacement therapy, particularly in patients undergoing HD. Is unknown if the results of patients undergoing HD were affected by the presence of diabetes.

Anahtar Kelimeler: Advanced glycated end products, advanced oxidation protein products, chronic renal failure, hemodialysis, peritoneal dialysis

PDF Görünüm

Referanslar

  • 1. Venus S, Teresa M, Rosa S, et al., Oxidative stress and cancer: an overview. Ageing Res Rev 12: 376-390, 2013. google scholar
  • 2. Cevat Yazıcı, Kader Köse: Kronik Böbrek Yetmezliğinde Oksidatif Stres ‘‘Biyomarkır’’ları: Nefroloji Dergisi 13:117-124, 2004. google scholar
  • 3. Himmerfalb J, Hakim RM: Oxidative stress in uremia. Curr Opin Nephrol Hypertens 12: 593–598, 2003. google scholar
  • 4. Danielski M, Ikizler A, McMonagle E, et al., Linkage of Hypoalbuminemia, Inflammation, and Oxidative Stress in Patients Receiving Maintenance Hemodialysis Therapy. Am J Kidney Dis 42 (2): 286-294, 2003. google scholar
  • 5. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, et al., Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304-1313, 1996. google scholar
  • 6. Massy ZA, Nguyen-Khoa T, Beauvais CH. Oxidative stress and chronic renal failure: markers and management. J Nephrol 15: 336-341, 2002. google scholar
  • 7. Vaziri ND. Oxidative Stress in Uremia: Nature, Mechanisms, and Potential Consequences. Semin Nephrol 24:469-473, 2004. google scholar
  • 8. Sundl I, Roob JM, Meinitzer A, et al., Antioxidant status of patients on peritoneal dialysis: Associations with inflammation and glycoxidative stress. Periton Dialysis Int 29: 89–101, 2008. google scholar
  • 9. Witowski J, Jorres A, Korybalska K, et al., Glucose degradation products in peritoneal dialysis fluids: do they harm? Kidney Int Suppl 84:148–151, 2003. google scholar
  • 10. Miyata T, Devuyst O, Kurokawa K, et al., Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes. Kidney Int 61:375–86, 2002. google scholar
  • 11. Lameire N, Vanholder R, De Smet R. Uremic toxins and peritoneal dialysis. Kidney Int 59: 292-297, 2001. google scholar
  • 12. Selmeci L, Seres L, Antal M, et al., Advanced oxidation protein products (AOPP) for monitoring oxidative stres in critically ill patients, fast and inexpensive automated technique; Clin Chem Lab Med 43(3): 294-297, 2005. google scholar
  • 13. Kaluosova M, Skrha J, Zima T. Advanced Glycation End-Products and Advanced Oxidation Protein Products in Patients with Diabetes Mellitus. Physiol. Res. 51: 597-604, 2002. google scholar
  • 14. Toborek M, Wasik T, Drózdz M et al., Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure. Metabolism 41: 1229–1232, 1992. google scholar
  • 15. Epperlein MM, Nourooz‐Zadeh J, Jayasena SD et al., Nature and biological significance of free radicals generated during bicarbonate hemodialysis. J Am Soc Nephrol 9: 457–46, 1998. google scholar
  • 16. Nguyen-Khoa T, Massy ZA. De Bandt PJ, et al., Oxidative stress and hemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant 16: 335-340, 2001. google scholar
  • 17. Witko-Sarsat V, Friendlander M, Nguyen-Khoa T, et al., Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161: 2524-2532, 1998. google scholar
  • 18. Descamps-Latscha B, Witko-Sarsat V. Importance of oxidatively modified proteins in chronic renal failure. Kidney Int 59:108-113, 2001. google scholar
  • 19. Chen MF, Chang CL, Liou SY. Increase in resting levels of superoxide anion in the whole blood of uremic patients on chronic hemodialysis. Blood Purif; 16: 290-300, 1998. google scholar
  • 20. Ward R, Meleisin K. Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. J Am Soc Nephrol, 5: 1967-1702, 1994. google scholar
  • 21. Craddack PR, Hammerschmidt DE. Complement-mediated granulocyte activation and down-regulation during hemodialysis. ASAIO J 7: 50-56, 1984. google scholar
  • 22. Hörl HW, Riegel W, Schollmeyer P. Different complement and granulocyte activation in patient dialyzed with PMMA dialyzers. Clin Nephrol 25: 304-307, 1986. google scholar
  • 23. Stroncek DF, Keshaviah P, Craddock PR, et al., Effect of dialyzer reuse on complement activation and neutropenia in hemodialysis. J Lab Clin Med. 104: 304-311, 1984. google scholar
  • 24. Höllgren R, Venge P, Danielson BG. Neutrophil and eosinophil degranulation during hemodialysis are mediated by the dialysis membrane. Nephron 32: 329-334, 1982. google scholar
  • 25. Hörl WH, Riegel W, Steinhauer HB, et al., Granulocyte activation during hemodialysis. Clin Nephrol 26: 30-34, 1986. google scholar
  • 26. Dalle-Donne I, Rossi R, Giustarini D, et al., Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329:23-38, 2003. google scholar
  • 27. Mimic-Oka J, Simic T, Pljesa M, et al., Oxidative modification of plasma proteins in different stages of chronic renal failure. Med Biol 8:1-5, 2001. google scholar
  • 28. Witko-Sarsat V, Nguyen-Khoa T, Jungers P, et al., Advanced oxidation protein products as a novel molecular basis of oxidative stress in uremia. Nephrol Dial Transplant 14:76-78, 1999. google scholar
  • 29. Amore A, Coppo R. Immunological basis of inflammation in dialysis. Nephrol Daial Transplant 17: 16-24, 2002. google scholar
  • 30. Köken T, Kahraman A, Serteser M, et al., Hemodiyaliz ve Oksidatif Stres. Karatepe Tıp Dergisi 5 (Ek Sayı): 9-13, 2004. google scholar
  • 31. Donate T, Herreros A, Martinez E, et al., Protein oxidative stress in dialysis patients. Adv Perit Dial 18: 15-17, 2002. google scholar
  • 32. Kumano K, Yokota S, Go M, et al., Quantitative and qualitative changes of serum albumin in CAPD patients. Adv Perit Dial 8: 127-130, 1992. google scholar
  • 33. Miyata T, Sugiyama S, Saito A, et al., Reactive carbonyl compounds related uremic toxicity (carbonyl stress). Kidney Int 59: 25-31,2001. google scholar
  • 34. Himmelfarb J, Mc Monagle E, McMenamin E. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int 58: 2571-2578, 2000. google scholar
  • 35. Kalousov M, Krha J, Zima T. Advanced Glycation End-Products and Advanced Oxidation Protein Products in Patients with Diabetes Mellitus. Physiol. Res. 51: 597-604, 2002. google scholar
  • 36. Kalousov M, Krha J, Tesar V, et al., Advanced Glycation End Products and Advanced Oxidation Protein Products in Hemodialyzed Patients. Blood Purif 20:531–536, 2002. google scholar
  • 37. Matteucci E, Biasci E, Giampietro O. Advanced oxidation protein products in plasma: stability during storage and correlation with other clinical characteistics. Acta Diabetol 38: 187-189, 2001. google scholar
  • 38. Witko-Sarsat V, Gausson V, Descamps-Latscha B. Are advanced oxidation protein products potential uremic toxins? Kidney Int 63:11-14, 2003. google scholar

Atıflar

Biçimlendirilmiş bir atıfı kopyalayıp yapıştırın veya seçtiğiniz biçimde dışa aktarmak için seçeneklerden birini kullanın


DIŞA AKTAR



APA

Coşkun, C., Kural, A., & Koldaş, M. (2018). Diyaliz Tedavisi Uygulanan ve Uygulanmayan Kronik Böbrek Yetmezlikli Hastalarda Protein Oksidasyon Ürünlerinin Değerlendirilmesi. Experimed, 8(1), 11-17. https://doi.org/10.26650/experimed.2018.430561


AMA

Coşkun C, Kural A, Koldaş M. Diyaliz Tedavisi Uygulanan ve Uygulanmayan Kronik Böbrek Yetmezlikli Hastalarda Protein Oksidasyon Ürünlerinin Değerlendirilmesi. Experimed. 2018;8(1):11-17. https://doi.org/10.26650/experimed.2018.430561


ABNT

Coşkun, C.; Kural, A.; Koldaş, M. Diyaliz Tedavisi Uygulanan ve Uygulanmayan Kronik Böbrek Yetmezlikli Hastalarda Protein Oksidasyon Ürünlerinin Değerlendirilmesi. Experimed, [Publisher Location], v. 8, n. 1, p. 11-17, 2018.


Chicago: Author-Date Style

Coşkun, Cihan, and Alev Kural and Macit Koldaş. 2018. “Diyaliz Tedavisi Uygulanan ve Uygulanmayan Kronik Böbrek Yetmezlikli Hastalarda Protein Oksidasyon Ürünlerinin Değerlendirilmesi.” Experimed 8, no. 1: 11-17. https://doi.org/10.26650/experimed.2018.430561


Chicago: Humanities Style

Coşkun, Cihan, and Alev Kural and Macit Koldaş. “Diyaliz Tedavisi Uygulanan ve Uygulanmayan Kronik Böbrek Yetmezlikli Hastalarda Protein Oksidasyon Ürünlerinin Değerlendirilmesi.” Experimed 8, no. 1 (May. 2025): 11-17. https://doi.org/10.26650/experimed.2018.430561


Harvard: Australian Style

Coşkun, C & Kural, A & Koldaş, M 2018, 'Diyaliz Tedavisi Uygulanan ve Uygulanmayan Kronik Böbrek Yetmezlikli Hastalarda Protein Oksidasyon Ürünlerinin Değerlendirilmesi', Experimed, vol. 8, no. 1, pp. 11-17, viewed 22 May. 2025, https://doi.org/10.26650/experimed.2018.430561


Harvard: Author-Date Style

Coşkun, C. and Kural, A. and Koldaş, M. (2018) ‘Diyaliz Tedavisi Uygulanan ve Uygulanmayan Kronik Böbrek Yetmezlikli Hastalarda Protein Oksidasyon Ürünlerinin Değerlendirilmesi’, Experimed, 8(1), pp. 11-17. https://doi.org/10.26650/experimed.2018.430561 (22 May. 2025).


MLA

Coşkun, Cihan, and Alev Kural and Macit Koldaş. “Diyaliz Tedavisi Uygulanan ve Uygulanmayan Kronik Böbrek Yetmezlikli Hastalarda Protein Oksidasyon Ürünlerinin Değerlendirilmesi.” Experimed, vol. 8, no. 1, 2018, pp. 11-17. [Database Container], https://doi.org/10.26650/experimed.2018.430561


Vancouver

Coşkun C, Kural A, Koldaş M. Diyaliz Tedavisi Uygulanan ve Uygulanmayan Kronik Böbrek Yetmezlikli Hastalarda Protein Oksidasyon Ürünlerinin Değerlendirilmesi. Experimed [Internet]. 22 May. 2025 [cited 22 May. 2025];8(1):11-17. Available from: https://doi.org/10.26650/experimed.2018.430561 doi: 10.26650/experimed.2018.430561


ISNAD

Coşkun, Cihan - Kural, Alev - Koldaş, Macit. “Diyaliz Tedavisi Uygulanan ve Uygulanmayan Kronik Böbrek Yetmezlikli Hastalarda Protein Oksidasyon Ürünlerinin Değerlendirilmesi”. Experimed 8/1 (May. 2025): 11-17. https://doi.org/10.26650/experimed.2018.430561



ZAMAN ÇİZELGESİ


Kabul04.06.2018

LİSANS


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


PAYLAŞ



İstanbul Üniversitesi Yayınları, uluslararası yayıncılık standartları ve etiğine uygun olarak, yüksek kalitede bilimsel dergi ve kitapların yayınlanmasıyla giderek artan bilimsel bilginin yayılmasına katkıda bulunmayı amaçlamaktadır. İstanbul Üniversitesi Yayınları açık erişimli, ticari olmayan, bilimsel yayıncılığı takip etmektedir.